These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 27981472)

  • 1. Neuroprotective Effects of Echinacoside on Regulating the Stress-Active p38MAPK and NF-κB p52 Signals in the Mice Model of Parkinson's Disease.
    Zhang J; Zhang Z; Xiang J; Cai M; Yu Z; Li X; Wu T; Cai D
    Neurochem Res; 2017 Apr; 42(4):975-985. PubMed ID: 27981472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Echinacoside protects dopaminergic neurons by inhibiting NLRP3/Caspase-1/IL-1β signaling pathway in MPTP-induced Parkinson's disease model.
    Gao MR; Wang M; Jia YY; Tian DD; Liu A; Wang WJ; Yang L; Chen JY; Yang Q; Liu R; Wu YM
    Brain Res Bull; 2020 Nov; 164():55-64. PubMed ID: 32846198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-124 regulates the expression of MEKK3 in the inflammatory pathogenesis of Parkinson's disease.
    Yao L; Ye Y; Mao H; Lu F; He X; Lu G; Zhang S
    J Neuroinflammation; 2018 Jan; 15(1):13. PubMed ID: 29329581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tanshinone I selectively suppresses pro-inflammatory genes expression in activated microglia and prevents nigrostriatal dopaminergic neurodegeneration in a mouse model of Parkinson's disease.
    Wang S; Jing H; Yang H; Liu Z; Guo H; Chai L; Hu L
    J Ethnopharmacol; 2015 Apr; 164():247-55. PubMed ID: 25666429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease.
    Du Y; Ma Z; Lin S; Dodel RC; Gao F; Bales KR; Triarhou LC; Chernet E; Perry KW; Nelson DL; Luecke S; Phebus LA; Bymaster FP; Paul SM
    Proc Natl Acad Sci U S A; 2001 Dec; 98(25):14669-74. PubMed ID: 11724929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calycosin attenuates MPTP-induced Parkinson's disease by suppressing the activation of TLR/NF-κB and MAPK pathways.
    Yang J; Jia M; Zhang X; Wang P
    Phytother Res; 2019 Feb; 33(2):309-318. PubMed ID: 30421460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Key Lipoprotein Receptor Targeted Echinacoside-Liposomes Effective Against Parkinson's Disease in Mice Model.
    Ou Z; You Y; Yi H; Liu X; Tong Y; Liu D; Wang J
    Int J Nanomedicine; 2024; 19():8463-8483. PubMed ID: 39185346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phytic acid attenuates inflammatory responses and the levels of NF-κB and p-ERK in MPTP-induced Parkinson's disease model of mice.
    Lv Y; Zhang Z; Hou L; Zhang L; Zhang J; Wang Y; Liu C; Xu P; Liu L; Gai X; Lu T
    Neurosci Lett; 2015 Jun; 597():132-6. PubMed ID: 25929185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attenuation of neuroinflammatory responses and behavioral deficits by Ligusticum officinale (Makino) Kitag in stimulated microglia and MPTP-induced mouse model of Parkinson's disease.
    Kim BW; Koppula S; Park SY; Kim YS; Park PJ; Lim JH; Kim IS; Choi DK
    J Ethnopharmacol; 2015 Apr; 164():388-97. PubMed ID: 25449453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cordycepin mitigates MPTP-induced Parkinson's disease through inhibiting TLR/NF-κB signaling pathway.
    Cheng C; Zhu X
    Life Sci; 2019 Apr; 223():120-127. PubMed ID: 30790609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurotrophic and neurorescue effects of Echinacoside in the subacute MPTP mouse model of Parkinson's disease.
    Zhao Q; Gao J; Li W; Cai D
    Brain Res; 2010 Jul; 1346():224-36. PubMed ID: 20478277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective effect of dextromethorphan in the MPTP Parkinson's disease model: role of NADPH oxidase.
    Zhang W; Wang T; Qin L; Gao HM; Wilson B; Ali SF; Zhang W; Hong JS; Liu B
    FASEB J; 2004 Mar; 18(3):589-91. PubMed ID: 14734632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Echinacoside exerts neuroprotection via suppressing microglial α-synuclein/TLR2/NF-κB/NLRP3 axis in parkinsonian models.
    Yang XP; Huang JH; Ye FL; Yv QY; Chen S; Li WW; Zhu M
    Phytomedicine; 2024 Jan; 123():155230. PubMed ID: 38000105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The phosphodiesterase 10 inhibitor papaverine exerts anti-inflammatory and neuroprotective effects via the PKA signaling pathway in neuroinflammation and Parkinson's disease mouse models.
    Lee YY; Park JS; Leem YH; Park JE; Kim DY; Choi YH; Park EM; Kang JL; Kim HS
    J Neuroinflammation; 2019 Dec; 16(1):246. PubMed ID: 31791357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of p38 MAPK in the substantia nigra leads to nuclear translocation of NF-kappaB in MPTP-treated mice: implication in Parkinson's disease.
    Karunakaran S; Ravindranath V
    J Neurochem; 2009 Jun; 109(6):1791-9. PubMed ID: 19457134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acorus gramineus inhibits microglia mediated neuroinflammation and prevents neurotoxicity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced mouse model of Parkinson's disease.
    Jiang J; Kim JJ; Kim DY; Kim MK; Oh NH; Koppula S; Park PJ; Choi DK; Shin YK; Kim IH; Kang TB; Lee KH
    J Ethnopharmacol; 2012 Dec; 144(3):506-13. PubMed ID: 23085397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isobavachalcone Attenuates MPTP-Induced Parkinson's Disease in Mice by Inhibition of Microglial Activation through NF-κB Pathway.
    Jing H; Wang S; Wang M; Fu W; Zhang C; Xu D
    PLoS One; 2017; 12(1):e0169560. PubMed ID: 28060896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rg1 improves LPS-induced Parkinsonian symptoms in mice via inhibition of NF-κB signaling and modulation of M1/M2 polarization.
    Liu JQ; Zhao M; Zhang Z; Cui LY; Zhou X; Zhang W; Chu SF; Zhang DY; Chen NH
    Acta Pharmacol Sin; 2020 Apr; 41(4):523-534. PubMed ID: 32203085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective effects of echinacoside in the mouse MPTP model of Parkinson's disease.
    Geng X; Tian X; Tu P; Pu X
    Eur J Pharmacol; 2007 Jun; 564(1-3):66-74. PubMed ID: 17359968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The orphan nuclear receptor Nurr1 agonist amodiaquine mediates neuroprotective effects in 6-OHDA Parkinson's disease animal model by enhancing the phosphorylation of P38 mitogen-activated kinase but not PI3K/AKT signaling pathway.
    Kambey PA; Chengcheng M; Xiaoxiao G; Abdulrahman AA; Kanwore K; Nadeem I; Jiao W; Gao D
    Metab Brain Dis; 2021 Apr; 36(4):609-625. PubMed ID: 33507465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.